Global Adenovirus Vector Vaccine Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
SKU ID : QYR-18655428 | Publishing Date : 28-Jun-2021 | No. of pages : 119
Detailed TOC of Global Adenovirus Vector Vaccine Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
1 Market Overview of Adenovirus Vector Vaccine1.1 Adenovirus Vector Vaccine Market Overview
1.1.1 Adenovirus Vector Vaccine Product Scope
1.1.2 Adenovirus Vector Vaccine Market Status and Outlook
1.2 Global Adenovirus Vector Vaccine Market Size Overview by Region 2016 VS 2021VS 2027
1.3 Global Adenovirus Vector Vaccine Market Size by Region (2016-2027)
1.4 Global Adenovirus Vector Vaccine Historic Market Size by Region (2016-2021)
1.5 Global Adenovirus Vector Vaccine Market Size Forecast by Region (2022-2027)
1.6 Key Regions, Adenovirus Vector Vaccine Market Size (2016-2027)
1.6.1 North America Adenovirus Vector Vaccine Market Size (2016-2027)
1.6.2 Europe Adenovirus Vector Vaccine Market Size (2016-2027)
1.6.3 Asia-Pacific Adenovirus Vector Vaccine Market Size (2016-2027)
1.6.4 Latin America Adenovirus Vector Vaccine Market Size (2016-2027)
1.6.5 Middle East & Africa Adenovirus Vector Vaccine Market Size (2016-2027)
2 Adenovirus Vector Vaccine Market Overview by Type
2.1 Global Adenovirus Vector Vaccine Market Size by Type: 2016 VS 2021 VS 2027
2.2 Global Adenovirus Vector Vaccine Historic Market Size by Type (2016-2021)
2.3 Global Adenovirus Vector Vaccine Forecasted Market Size by Type (2022-2027)
2.4 Being Developed
2.5 Preclinical
2.6 Clinical I
2.7 Clinical II
3 Adenovirus Vector Vaccine Market Overview by Application
3.1 Global Adenovirus Vector Vaccine Market Size by Application: 2016 VS 2021 VS 2027
3.2 Global Adenovirus Vector Vaccine Historic Market Size by Application (2016-2021)
3.3 Global Adenovirus Vector Vaccine Forecasted Market Size by Application (2022-2027)
3.4 Pharmaceutical And Biotechnology Companies
3.5 Hospital
3.6 Academic And Research Organizations
3.7 Other
4 Adenovirus Vector Vaccine Competition Analysis by Players
4.1 Global Adenovirus Vector Vaccine Market Size by Players (2016-2021)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Adenovirus Vector Vaccine as of 2020)
4.3 Date of Key Players Enter into Adenovirus Vector Vaccine Market
4.4 Global Top Players Adenovirus Vector Vaccine Headquarters and Area Served
4.5 Key Players Adenovirus Vector Vaccine Product Solution and Service
4.6 Competitive Status
4.6.1 Adenovirus Vector Vaccine Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Johnson & Johnson
5.1.1 Johnson & Johnson Profile
5.1.2 Johnson & Johnson Main Business
5.1.3 Johnson & Johnson Adenovirus Vector Vaccine Products, Services and Solutions
5.1.4 Johnson & Johnson Adenovirus Vector Vaccine Revenue (US$ Million) & (2016-2021)
5.1.5 Johnson & Johnson Recent Developments
5.2 CanSino Biologics
5.2.1 CanSino Biologics Profile
5.2.2 CanSino Biologics Main Business
5.2.3 CanSino Biologics Adenovirus Vector Vaccine Products, Services and Solutions
5.2.4 CanSino Biologics Adenovirus Vector Vaccine Revenue (US$ Million) & (2016-2021)
5.2.5 CanSino Biologics Recent Developments
5.3 Greffex
5.5.1 Greffex Profile
5.3.2 Greffex Main Business
5.3.3 Greffex Adenovirus Vector Vaccine Products, Services and Solutions
5.3.4 Greffex Adenovirus Vector Vaccine Revenue (US$ Million) & (2016-2021)
5.3.5 BravoBio Recent Developments
5.4 BravoBio
5.4.1 BravoBio Profile
5.4.2 BravoBio Main Business
5.4.3 BravoBio Adenovirus Vector Vaccine Products, Services and Solutions
5.4.4 BravoBio Adenovirus Vector Vaccine Revenue (US$ Million) & (2016-2021)
5.4.5 BravoBio Recent Developments
5.5 Altimmune
5.5.1 Altimmune Profile
5.5.2 Altimmune Main Business
5.5.3 Altimmune Adenovirus Vector Vaccine Products, Services and Solutions
5.5.4 Altimmune Adenovirus Vector Vaccine Revenue (US$ Million) & (2016-2021)
5.5.5 Altimmune Recent Developments
...
6 North America
6.1 North America Adenovirus Vector Vaccine Market Size by Country (2016-2027)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Adenovirus Vector Vaccine Market Size by Country (2016-2027)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Adenovirus Vector Vaccine Market Size by Region (2016-2027)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Adenovirus Vector Vaccine Market Size by Country (2016-2027)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Adenovirus Vector Vaccine Market Size by Country (2016-2027)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Adenovirus Vector Vaccine Market Dynamics
11.1 Adenovirus Vector Vaccine Industry Trends
11.2 Adenovirus Vector Vaccine Market Drivers
11.3 Adenovirus Vector Vaccine Market Challenges
11.4 Adenovirus Vector Vaccine Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Figures, Tables and Charts Available in Global Adenovirus Vector Vaccine Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
List of TablesTable 1. Global Market Adenovirus Vector Vaccine Market Size (US$ Million) Comparison by Region 2016 VS 2021 VS 2027
Table 2. Global Adenovirus Vector Vaccine Market Size by Region (2016-2021) & (US$ Million)
Table 3. Global Adenovirus Vector Vaccine Market Size Share by Region (2016-2021)
Table 4. Global Adenovirus Vector Vaccine Forecasted Market Size by Region (2022-2027) & (US$ Million)
Table 5. Global Adenovirus Vector Vaccine Forecasted Market Size Share by Region (2022-2027)
Table 6. Global Adenovirus Vector Vaccine Market Size (US$ Million) by Type: 2016 VS 2021 VS 2027
Table 7. Global Adenovirus Vector Vaccine Market Size by Type (2016-2021) & (US$ Million)
Table 8. Global Adenovirus Vector Vaccine Revenue Market Share by Type (2016-2021)
Table 9. Global Adenovirus Vector Vaccine Forecasted Market Size by Type (2022-2027) & (US$ Million)
Table 10. Global Adenovirus Vector Vaccine Revenue Market Share by Type (2022-2027)
Table 11. Global Adenovirus Vector Vaccine Market Size (US$ Million) by Application: 2016 VS 2021 VS 2027
Table 12. Global Adenovirus Vector Vaccine Market Size by Application (2016-2021) & (US$ Million)
Table 13. Global Adenovirus Vector Vaccine Revenue Market Share by Application (2016-2021)
Table 14. Global Adenovirus Vector Vaccine Forecasted Market Size by Application (2022-2027) & (US$ Million)
Table 15. Global Adenovirus Vector Vaccine Revenue Market Share by Application (2022-2027)
Table 16. Global Adenovirus Vector Vaccine Revenue (US$ Million) by Players (2016-2021)
Table 17. Global Adenovirus Vector Vaccine Revenue Market Share by Players (2016-2021)
Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Adenovirus Vector Vaccine as of 2020)
Table 19. Date of Key Manufacturers Enter into Adenovirus Vector Vaccine Market
Table 20. Global Adenovirus Vector Vaccine Top Players Headquarters and Area Served
Table 21. Adenovirus Vector Vaccine Product Solution and Service
Table 22. Global Adenovirus Vector Vaccine Players Market Concentration Ratio (CR5 and HHI)
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Johnson & Johnson Basic Information List
Table 25. Johnson & Johnson Description and Business Overview
Table 26. Johnson & Johnson Adenovirus Vector Vaccine Products, Services and Solutions
Table 27. Revenue (US$ Million) in Adenovirus Vector Vaccine Business of Johnson & Johnson (2016-2021)
Table 28. Johnson & Johnson Recent Developments
Table 29. CanSino Biologics Basic Information List
Table 30. CanSino Biologics Description and Business Overview
Table 31. CanSino Biologics Adenovirus Vector Vaccine Products, Services and Solutions
Table 32. Revenue (US$ Million) in Adenovirus Vector Vaccine Business of CanSino Biologics (2016-2021)
Table 33. CanSino Biologics Recent Developments
Table 34. Greffex Basic Information List
Table 35. Greffex Description and Business Overview
Table 36. Greffex Adenovirus Vector Vaccine Products, Services and Solutions
Table 37. Revenue (US$ Million) in Adenovirus Vector Vaccine Business of Greffex (2016-2021)
Table 38. Greffex Recent Developments
Table 39. BravoBio Basic Information List
Table 40. BravoBio Description and Business Overview
Table 41. BravoBio Adenovirus Vector Vaccine Products, Services and Solutions
Table 42. Revenue (US$ Million) in Adenovirus Vector Vaccine Business of BravoBio (2016-2021)
Table 43. BravoBio Recent Developments
Table 44. Altimmune Basic Information List
Table 45. Altimmune Description and Business Overview
Table 46. Altimmune Adenovirus Vector Vaccine Products, Services and Solutions
Table 47. Revenue (US$ Million) in Adenovirus Vector Vaccine Business of Altimmune (2016-2021)
Table 48. Altimmune Recent Developments
Table 49. North America Adenovirus Vector Vaccine Market Size by Country (2016-2021) & (US$ Million)
Table 50. North America Adenovirus Vector Vaccine Market Size by Country (2022-2027) & (US$ Million)
Table 51. Europe Adenovirus Vector Vaccine Market Size by Country (2016-2021) & (US$ Million)
Table 52. Europe Adenovirus Vector Vaccine Market Size by Country (2022-2027) & (US$ Million)
Table 53. Asia-Pacific Adenovirus Vector Vaccine Market Size by Region (2016-2021) & (US$ Million)
Table 54. Asia-Pacific Adenovirus Vector Vaccine Market Size by Region (2022-2027) & (US$ Million)
Table 55. Asia-Pacific Adenovirus Vector Vaccine Market Share by Region (2016-2021)
Table 56. Asia-Pacific Adenovirus Vector Vaccine Market Share by Region (2022-2027)
Table 57. Latin America Adenovirus Vector Vaccine Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Adenovirus Vector Vaccine Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Adenovirus Vector Vaccine Market Size by Players (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Adenovirus Vector Vaccine Market Size by Country (2022-2027) & (US$ Million)
Table 61. Adenovirus Vector Vaccine Market Trends
Table 62. Adenovirus Vector Vaccine Market Drivers
Table 63. Adenovirus Vector Vaccine Market Challenges
Table 64. Adenovirus Vector Vaccine Market Restraints
Table 65. Research Programs/Design for This Report
Table 66. Key Data Information from Secondary Sources
Table 67. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Adenovirus Vector Vaccine Market Size Year-over-Year 2016-2027 & (US$ Million)
Figure 2. Global Adenovirus Vector Vaccine Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 3. Global Adenovirus Vector Vaccine Market Share by Regions: 2021 VS 2027
Figure 4. Global Adenovirus Vector Vaccine Forecasted Market Size Share by Region (2022-2027)
Figure 5. North America Adenovirus Vector Vaccine Market Size (US$ Million) Growth Rate (2016-2027)
Figure 6. Europe Adenovirus Vector Vaccine Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 7. Asia-Pacific Adenovirus Vector Vaccine Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 8. Latin America Adenovirus Vector Vaccine Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 9. Middle East & Africa Adenovirus Vector Vaccine Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 10. Global Adenovirus Vector Vaccine Market Size Share by Type in 2021 & 2027
Figure 11. Being Developed Market Size (US$ Million) YoY Growth (2016-2027)
Figure 12. Preclinical Market Size (US$ Million) YoY Growth (2016-2027)
Figure 13. Clinical I Market Size (US$ Million) YoY Growth (2016-2027)
Figure 14. Clinical II Market Size (US$ Million) YoY Growth (2016-2027)
Figure 15. Global Adenovirus Vector Vaccine Market Size Share by Application in 2021 & 2027
Figure 16. Pharmaceutical And Biotechnology Companies Market Size (US$ Million) YoY Growth (2016-2027)
Figure 17. Hospital Market Size (US$ Million) YoY Growth (2016-2027)
Figure 18. Academic And Research Organizations Market Size (US$ Million) YoY Growth (2016-2027)
Figure 19. Other Market Size (US$ Million) YoY Growth (2016-2027)
Figure 20. Adenovirus Vector Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 21. Global Top 5 and Top 10 Players Adenovirus Vector Vaccine Market Share in 2020
Figure 22. North America Adenovirus Vector Vaccine Market Share by Country (2016-2027)
Figure 23. United States Adenovirus Vector Vaccine Market Size (2016-2027) & (US$ Million)
Figure 24. Canada Adenovirus Vector Vaccine Market Size (2016-2027) & (US$ Million)
Figure 25. Germany Adenovirus Vector Vaccine Market Size (2016-2027) & (US$ Million)
Figure 26. France Adenovirus Vector Vaccine Market Size (2016-2027) & (US$ Million)
Figure 27. U.K. Adenovirus Vector Vaccine Market Size (2016-2027) & (US$ Million)
Figure 28. Italy Adenovirus Vector Vaccine Market Size (2016-2027) & (US$ Million)
Figure 29. Russia Adenovirus Vector Vaccine Market Size (2016-2027) & (US$ Million)
Figure 30. Nordic Adenovirus Vector Vaccine Market Size (2016-2027) & (US$ Million)
Figure 31. Rest of Europe Adenovirus Vector Vaccine Market Size (2016-2027) & (US$ Million)
Figure 32. Asia-Pacific Adenovirus Vector Vaccine Market Share by Region (2016-2027)
Figure 33. China Adenovirus Vector Vaccine Market Size (2016-2027) & (US$ Million)
Figure 34. Japan Adenovirus Vector Vaccine Market Size (2016-2027) & (US$ Million)
Figure 35. South Korea Adenovirus Vector Vaccine Market Size (2016-2027) & (US$ Million)
Figure 36. Southeast Asia Adenovirus Vector Vaccine Market Size (2016-2027) & (US$ Million)
Figure 37. India Adenovirus Vector Vaccine Market Size (2016-2027) & (US$ Million)
Figure 38. Australia Adenovirus Vector Vaccine Market Size (2016-2027) & (US$ Million)
Figure 39. Rest of Asia-Pacific Adenovirus Vector Vaccine Market Size (2016-2027) & (US$ Million)
Figure 40. Latin America Adenovirus Vector Vaccine Market Share by Country (2016-2027)
Figure 41. Mexico Adenovirus Vector Vaccine Market Size (2016-2027) & (US$ Million)
Figure 42. Brazil Adenovirus Vector Vaccine Market Size (2016-2027) & (US$ Million)
Figure 43. Rest of Latin America Adenovirus Vector Vaccine Market Size (2016-2027) & (US$ Million)
Figure 44. Middle East & Africa Adenovirus Vector Vaccine Market Share by Country (2016-2027)
Figure 45. Turkey Adenovirus Vector Vaccine Market Size (2016-2027) & (US$ Million)
Figure 46. Saudi Arabia Adenovirus Vector Vaccine Market Size (2016-2027) & (US$ Million)
Figure 47. UAE Adenovirus Vector Vaccine Market Size (2016-2027) & (US$ Million)
Figure 48. Rest of Middle East & Africa Adenovirus Vector Vaccine Market Size (2016-2027) & (US$ Million)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Keyplayers in Global Adenovirus Vector Vaccine Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
Johnson & JohnsonCanSino Biologics
Greffex
BravoBio
Altimmune